Basic Information
Basic information for PTPRG-AS1-214-63aa
Peptide Name PTPRG-AS1-214-63aa
Genome Position chr3:62261878-62262066[-]
Species Human
Peptide Sequence MEYSGVISAHCKLRLLGSCHSPALASRVAGTTGACHHARLIFVFLVETGFHRISQDGLDLLTS
Peptide Length 63
Unique No (PTPRG-AS1-201-63aa,PTPRG-AS1-204-63aa,PTPRG-AS1-205-63aa,PTPRG-AS1-211-63aa,PTPRG-AS1-212-63aa,PTPRG-AS1-213-63aa,PTPRG-AS1-217-63aa,PTPRG-AS1-218-63aa,PTPRG-AS1-219-63aa,PTPRG-AS1-221-63aa,PTPRG-AS1-222-63aa,PTPRG-AS1-223-63aa,PTPRG-AS1-226-63aa)
Grand Average of Hydropathicity 0.381
Relative Molecular Mass 7869.85
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000241472;PTPRG-AS1
Transcript ID/Name ENST00000660182;PTPRG-AS1-214
Transcript Length 2531
Coding Ability 0.3943
DNA Sequence Corresponding to Peptide ATGGAGTACAGTGGCGTGATCTCGGCTCACTGCAAGCTCCGCCTCCTGGGTTCATGCCATTCTCCTGCCTTAGCCTCCCGAGTAGCTGGGACTACAGGCGCCTGCCACCACGCCCGGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACCGCATTAGCCAGGATGGTCTCGATCTCCTGACCTCG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :